Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease

Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by extracellular amyloid plaques, predominantly consisting of amyloid-<i>β</i> (A<i>β</i>) peptides. The oligomeric form of A<i>β</i> is acknowledged as the most neurotoxic, propelling...

Full description

Saved in:
Bibliographic Details
Main Authors: Marilena K. Theodoropoulou, Konstantina D. Vraila, Nikos C. Papandreou, Georgia I. Nasi, Vassiliki A. Iconomidou
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/15/1/28
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588960657833984
author Marilena K. Theodoropoulou
Konstantina D. Vraila
Nikos C. Papandreou
Georgia I. Nasi
Vassiliki A. Iconomidou
author_facet Marilena K. Theodoropoulou
Konstantina D. Vraila
Nikos C. Papandreou
Georgia I. Nasi
Vassiliki A. Iconomidou
author_sort Marilena K. Theodoropoulou
collection DOAJ
description Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by extracellular amyloid plaques, predominantly consisting of amyloid-<i>β</i> (A<i>β</i>) peptides. The oligomeric form of A<i>β</i> is acknowledged as the most neurotoxic, propelling the pathological progression of AD. Interestingly, besides A<i>β</i>, other proteins are co-localized within amyloid plaques. Peptide analogs corresponding to the “aggregation-prone” regions (APRs) of these proteins could exhibit high-affinity binding to A<i>β</i> and significant inhibitory potential against the A<i>β</i> oligomerization process. The peptide analogs of co-localized protease, Cathepsin B, may act as such potent inhibitors. In silico studies on the complexes of the oligomeric state of A<i>β</i> and Cathepsin B peptide analogs were performed utilizing molecular docking and molecular dynamics simulations, revealing that these analogs disrupt the <i>β</i>-sheet-rich core of A<i>β</i> oligomers, a critical structural feature of their stability. Of the four peptide analogs evaluated, two demonstrated considerable potential by effectively destabilizing oligomers while maintaining low self-aggregation propensity, i.e., a crucial consideration for therapeutic safety. These findings point out the potential of APR-derived peptide analogs from co-localized proteins as innovative agents against AD, paving the way for further exploration in peptide-based therapeutic development.
format Article
id doaj-art-34065866ef1946eeaf83e135304c59f5
institution Kabale University
issn 2218-273X
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-34065866ef1946eeaf83e135304c59f52025-01-24T13:24:54ZengMDPI AGBiomolecules2218-273X2024-12-011512810.3390/biom15010028Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s DiseaseMarilena K. Theodoropoulou0Konstantina D. Vraila1Nikos C. Papandreou2Georgia I. Nasi3Vassiliki A. Iconomidou4Section of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 01 Athens, GreeceSection of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 01 Athens, GreeceSection of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 01 Athens, GreeceSection of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 01 Athens, GreeceSection of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 157 01 Athens, GreeceAlzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by extracellular amyloid plaques, predominantly consisting of amyloid-<i>β</i> (A<i>β</i>) peptides. The oligomeric form of A<i>β</i> is acknowledged as the most neurotoxic, propelling the pathological progression of AD. Interestingly, besides A<i>β</i>, other proteins are co-localized within amyloid plaques. Peptide analogs corresponding to the “aggregation-prone” regions (APRs) of these proteins could exhibit high-affinity binding to A<i>β</i> and significant inhibitory potential against the A<i>β</i> oligomerization process. The peptide analogs of co-localized protease, Cathepsin B, may act as such potent inhibitors. In silico studies on the complexes of the oligomeric state of A<i>β</i> and Cathepsin B peptide analogs were performed utilizing molecular docking and molecular dynamics simulations, revealing that these analogs disrupt the <i>β</i>-sheet-rich core of A<i>β</i> oligomers, a critical structural feature of their stability. Of the four peptide analogs evaluated, two demonstrated considerable potential by effectively destabilizing oligomers while maintaining low self-aggregation propensity, i.e., a crucial consideration for therapeutic safety. These findings point out the potential of APR-derived peptide analogs from co-localized proteins as innovative agents against AD, paving the way for further exploration in peptide-based therapeutic development.https://www.mdpi.com/2218-273X/15/1/28Alzheimer’s diseaseCathepsin Baggregation-prone regionsamyloid-<i>β</i>A<i>β</i>molecular dynamics
spellingShingle Marilena K. Theodoropoulou
Konstantina D. Vraila
Nikos C. Papandreou
Georgia I. Nasi
Vassiliki A. Iconomidou
Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
Biomolecules
Alzheimer’s disease
Cathepsin B
aggregation-prone regions
amyloid-<i>β</i>
A<i>β</i>
molecular dynamics
title Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
title_full Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
title_fullStr Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
title_full_unstemmed Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
title_short Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
title_sort co localized in amyloid plaques cathepsin b as a source of peptide analogs potential drug candidates for alzheimer s disease
topic Alzheimer’s disease
Cathepsin B
aggregation-prone regions
amyloid-<i>β</i>
A<i>β</i>
molecular dynamics
url https://www.mdpi.com/2218-273X/15/1/28
work_keys_str_mv AT marilenaktheodoropoulou colocalizedinamyloidplaquescathepsinbasasourceofpeptideanalogspotentialdrugcandidatesforalzheimersdisease
AT konstantinadvraila colocalizedinamyloidplaquescathepsinbasasourceofpeptideanalogspotentialdrugcandidatesforalzheimersdisease
AT nikoscpapandreou colocalizedinamyloidplaquescathepsinbasasourceofpeptideanalogspotentialdrugcandidatesforalzheimersdisease
AT georgiainasi colocalizedinamyloidplaquescathepsinbasasourceofpeptideanalogspotentialdrugcandidatesforalzheimersdisease
AT vassilikiaiconomidou colocalizedinamyloidplaquescathepsinbasasourceofpeptideanalogspotentialdrugcandidatesforalzheimersdisease